US 8415384
Reducing myocardial reperfusion injury by the combination therapy of protein kinase A activation and B1-adrenergic receptor blockade
granted A61KA61K31/24A61K31/444
Quick answer
US patent 8415384 (Reducing myocardial reperfusion injury by the combination therapy of protein kinase A activation and B1-adrenergic receptor blockade) held by The Board of Regents of the University of Texas System expires Mon Apr 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Apr 09 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K31/24, A61K31/444, A61K45/06, A61P